Table 3. The top 10 pathways that could be affected by clopidogrel in the GES-1 cells.

Pathway	P-value*	FDR**	Gene involved
1. ECM-receptor interaction	0	0	AGRN, COL1A1, COL5A1, LAMA5
2. Focal adhesion	2.00E-04	1.00E-04	COL1A1, COL5A1, LAMA5, VEGFA
3. MAPK signaling pathway	6.00E-04	2.00E-04	DDIT3, DUSP10, DUSP2, MYC
4. Nitrogen metabolism	6.00E-04	2.00E-04	ASNS, CTH
5. Alanine, aspartate and glutamatemetabolism	0.001	2.00E-04	ASNS, GPT2
6. Glycine, serine and threonine metabolis	0.001	2.00E-04	CTH, PSAT1
7. Pathways in cancer	0.0012	2.00E-04	LAMA5, MYC, VEGFA, WNT7B
8. Bladder cancer	0.0017	3.00E-04	MYC, VEGFA
9. p53 signaling pathway	0.0044	5.00E-04	PMAIP1, SESN2
10. Metabolic pathways	0.0046	5.00E-04	ASNS, CTH, DHRS3, GPT2, PCK2

^*Enrichment P-value of the corresponding pathway as determined by Fisher’s exact test.

^**FDR of the corresponding pathway.

Bold, up-regulated; non-bold, down-regulated.